Security Highlights 06/16/2014

By | |
Share This:9:29 AM ET, 06/16/2014 – Street Insider bluebird bio, Inc. (Nasdaq: BLUE) 63.3% HIGHER; released initial positive clinical data from its HGB-205 clinical study of its LentiGlobin BB305 product candidate in beta-thalassemia major subjects at the 19th Annual Congress of the European Hematology Association (EHA) in Milan, Italy. Covidien plc (NYSE: COV) 29.4% HIGHER; Medtronic, Inc. (NYSE: MDT), a global leader in medical technology, services and solutions, and Covidien plc (NYSE: COV), a global healthcare technology and medical supplies provider, today announced that they have entered into a definitive agreement under which Medtronic has agreed to acquire Covidien in a

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In
   
Forgot password? Click here to reset
New User Registration

*Required field
Bookmark the permalink.

About securitytradeideas

Our mission at Security Trade Ideas (STI) is to provide our readers with profitable Security Trade Ideas and to gain their trust by providing reliable and trustworthy financial information. We want to save you research time and money to enable you to manage your own portfolio. Our passion is to research and to find Security Trade Ideas. We would like to help our readers prosper.

Comments are closed.